Dr. Jillian Parker is a Supervising Health Scientist with Cardno ChemRisk, located in Aliso Viejo, California, with 3 years of professional experience in the areas of toxicology and human health risk assessment. She received her BS in biochemistry from the University of Akron, where she conducted research focused on the structure and function of bacterial metal-binding proteins the effects of elemental silver on proteins. Dr. Parker then completed her PhD in Chemistry & Chemical Biology at Northeastern University, which was focused on protein chemistry, structural biology, structure-function relationships, intramolecular cellular signaling pathways, and small molecule and biological pharmaceuticals. Dr. Parker’s primary areas of practice include the safety, toxicology, and potential risks of personal care and consumer products, pharmaceuticals, and electronic nicotine delivery systems (ENDS). She is also the co-lead of the Consumer Products Initiative.

Prior to joining the firm, Dr. Parker was employed as a Patent Agent and specialized in pharmaceutical and biotechnology intellectual property and litigation support. She is registered to practice before the United States Patent and Trademark Office (USPTO).


  • PhD, Chemistry & Chemical Biology, Northeastern University, 2017
  • BS, Biochemistry, Applied Mathematics Minor, The University of Akron, 2012

Professional Associations

  • Society of Toxicology (SOT) - Full member (since 2018)
  • American Society for Biochemistry and Molecular Biology (ASBMB) – Student member (2013-2017)